PEG-GC

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePEG-GC
Drug Alias NameLysodasePEG-GCPEG-rGCPEG-rGCS
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionglucocerebroside hydrolysis activatorsGlucosylceramidase replacements
TargetsGlucosylceramide
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Mental HealthNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Mental HealthEnzon Pharmaceuticals Inc +[4] 
Active IndicationsN/A
Inactive IndicationsGaucher Disease

Other Information

ATC CodeN/A
Related LinksN/A